Intercept Pharmaceuticals' (NASDAQ:ICPT) stunning 280% gain on Thursday left shareholders smiling. Some may have expected shares to pull back today, as investors tend to lock in profits after such big gains, but the stock popped more than 60% today. In the following video, analysts David Williamson and Max Macaluso discuss this stock's stellar performance and why investors are pushing shares higher.

David Williamson has no position in any stocks mentioned. Max Macaluso, Ph.D. has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.